Skip to main content
    E

    Enlivex Therapeutics Ltd (ENLV)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.10
    -0.09 (-7.56%)

    Market Cap: $1.82M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Enlivex Therapeutics Ltd (ENLV) Earnings: Report Dates and Results

    Updated Sep 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Enlivex Therapeutics (ENLV) is expected to report earnings on Mar 23, 2027. In the quarter ended Jun 30, 2026, Enlivex Therapeutics reported EPS of -$1.20, below the -$0.31 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    54%(15/28)
    Avg Surprise
    -37.89%

    Upcoming Estimates

    Reports Mar 23, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$4.24
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    ENLV has an expected report date of Mar 23, 2027.

    Earnings History

    Of the 30 quarters below that had an estimate, ENLV beat 16, missed 12 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2026, when EPS landed 650.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jun 30, 2026-$1.20-$0.31-$0.31 - -$0.31-287.10%MissN/A10 up, 1 downSep 4, 2026
    Mar 31, 2026-$0.15-$0.02N/A-650.00%MissN/A10 up, 1 downJun 26, 2026
    Dec 31, 2025-$1.41-$0.45-$0.45 - -$0.45-213.33%MissN/A11 up, 0 downMar 25, 2026
    Sep 30, 2025-$1.35-$1.80-$1.80 - -$1.80+25.00%BeatN/A11 up, 0 downNov 14, 2025
    Jun 30, 2025-$1.20-$2.40-$2.40 - -$2.40+50.00%BeatN/A10 up, 1 downAug 29, 2025
    Mar 31, 2025-$2.25-$2.40-$2.40 - -$2.40+6.25%BeatN/A10 up, 1 downMay 30, 2025
    Dec 31, 2024-$0.23-$0.16-$0.16 - -$0.16-43.75%MissN/A11 up, 0 downFeb 26, 2025
    Sep 30, 2024-$1.80-$2.40-$2.40 - -$2.40+25.00%BeatN/A11 up, 0 downNov 29, 2024
    Jun 30, 2024-$2.40-$1.20N/A-100.00%MissN/A10 up, 0 downAug 30, 2024
    Mar 31, 2024-$3.30-$3.75-$3.75 - -$3.75+12.00%BeatN/A10 up, 0 downJun 14, 2024
    Dec 31, 2023-$7.20-$4.20N/A-71.43%MissN/AN/A0 up, 0 downMar 29, 2024
    Sep 30, 2023-$4.80-$4.80-$4.80 - -$4.800.00%In lineN/A11 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.40-$0.46-$0.46 - -$0.46+13.04%BeatN/A10 up, 0 downSep 1, 2023
    Mar 31, 2023-$5.85-$6.00-$6.00 - -$6.00+2.50%BeatN/A10 up, 0 downApr 4, 2023
    Dec 31, 2022-$5.85-$5.70-$5.70 - -$5.70-2.63%MissN/A10 up, 0 downMar 31, 2023
    Sep 30, 2022-$4.65-$4.35-$4.35 - -$4.35-6.90%MissN/A10 up, 0 downDec 5, 2022
    Jun 30, 2022-$8.10-$6.75N/A-20.00%MissN/AN/A0 up, 0 downAug 22, 2022
    Mar 31, 2022-$6.75-$6.15-$6.15 - -$6.15-9.76%MissN/A10 up, 0 downApr 29, 2022
    Sep 30, 2021-$2.85-$3.15-$3.15 - -$3.15+9.52%BeatN/A1N/ANov 22, 2021
    Jun 30, 2021-$2.55-$3.90-$3.90 - -$3.90+34.62%BeatN/A1N/AAug 9, 2021
    Mar 31, 2021-$2.85-$3.15N/A+9.52%BeatN/A1N/AApr 30, 2021
    Dec 31, 2020-$0.25-$0.24N/A-4.17%MissN/A1N/AFeb 26, 2021
    Sep 30, 2020-$2.40-$2.70-$2.70 - -$2.70+11.11%BeatN/A1N/AOct 30, 2020
    Jun 30, 2020-$3.45-$3.60-$3.60 - -$3.60+4.17%BeatN/A1N/AAug 14, 2020
    Mar 31, 2020-$1.05-$3.60-$3.60 - -$3.60+70.83%BeatN/A1N/AApr 30, 2020
    Dec 31, 2019-$0.25-$0.25N/A0.00%In lineN/AN/AN/AFeb 21, 2020
    Sep 30, 2019-$0.24N/AN/AN/AN/AN/AN/AN/ANov 14, 2019
    Jun 30, 2019-$0.16N/AN/AN/AN/AN/AN/AN/AJul 26, 2019
    Mar 31, 2019-$0.16N/AN/AN/AN/AN/AN/AN/AApr 30, 2019
    Dec 31, 2018-$0.16N/AN/AN/AN/AN/AN/AN/AMar 27, 2019
    Sep 30, 2018-$0.12N/AN/AN/AN/AN/AN/AN/ADec 31, 2018
    Jun 30, 2018-$0.50N/AN/AN/AN/AN/AN/AN/AJul 26, 2018
    Mar 31, 2018-$2.34N/AN/AN/AN/AN/AN/AN/AApr 6, 2018
    Dec 31, 2017-$0.16N/AN/AN/AN/AN/AN/AN/AFeb 23, 2018
    Sep 30, 2017-$2.56N/AN/AN/AN/AN/AN/AN/ANov 2, 2017
    Jun 30, 2017-$4.00N/AN/AN/AN/AN/AN/AN/AAug 4, 2017
    Mar 31, 2017-$6.40-$11.60N/A+44.83%BeatN/AN/AN/AMay 26, 2017
    Dec 31, 2016-$7.60-$10.80N/A+29.63%BeatN/AN/AN/AFeb 24, 2017
    Sep 30, 2016-$11.20-$8.80N/A-27.27%MissN/AN/AN/ANov 29, 2016
    Jun 30, 2016-$8.80-$10.80N/A+18.52%BeatN/AN/AN/AAug 25, 2016
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$6.21, after -$7.73 the year before. It was -$42.40 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$6.21N/A
    Dec 31, 2024-$7.73N/A
    Dec 31, 2023-$18.25N/A
    Dec 31, 2022-$33.60N/A
    Dec 31, 2020-$7.15N/A
    Dec 31, 2019-$0.81N/A
    Dec 31, 2018-$3.12N/A
    Dec 31, 2017-$13.12N/A
    Dec 31, 2016-$40.40N/A
    Dec 31, 2015-$42.40N/A

    Frequently Asked Questions About ENLV

    When is Enlivex Therapeutics's next earnings date?

    Enlivex Therapeutics's next earnings report is expected for Mar 23, 2027.

    Did ENLV beat earnings estimates last quarter?

    No. Enlivex Therapeutics reported EPS of -$1.20 for the quarter ended Jun 30, 2026, below the -$0.31 estimate by 287.10%.

    What EPS do analysts expect from ENLV next quarter?

    The consensus EPS estimate for Enlivex Therapeutics for the quarter ending Dec 31, 2026 is -$4.24 from 3 analysts.

    How often does ENLV beat earnings estimates?

    Enlivex Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -135.99%.